Silo Pharma, Inc. SEC filings SILO
Silo Pharma, Inc. has 378 filings in SEC EDGAR's recent list, going back to Mar 30, 2011. Its latest annual report, Form ARS, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jun 30, 2026 | — |
| DEF 14A | Proxy statement | Jun 30, 2026 | Aug 14, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 18, 2026 | Aug 14, 2026 |
| DEFA14A | Additional proxy material | Sep 5, 2025 | — |
| DEF 14A | Proxy statement | Sep 5, 2025 | Oct 24, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 25, 2025 | Aug 25, 2025 |
| DEFA14A | Additional proxy material | Nov 8, 2024 | — |
| DEFA14A | Additional proxy material | Sep 18, 2024 | — |
| DEF 14A | Proxy statement | Sep 18, 2024 | Nov 12, 2024 |
| DEFA14A | Additional proxy material | Oct 23, 2023 | — |
| DEF 14A | Proxy statement | Oct 23, 2023 | Dec 4, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2023 | Dec 4, 2023 |
| DEFA14A | Additional proxy material | Mar 7, 2022 | — |
| DEF 14A | Proxy statement | Feb 14, 2022 | Mar 11, 2022 |
| PRE 14A | Preliminary proxy statement | Feb 2, 2022 | Feb 2, 2022 |
| DEF 14A | Proxy statement | Feb 22, 2021 | Mar 10, 2021 |
| DEFA14A | Additional proxy material | Feb 16, 2021 | — |
| PRE 14A | Preliminary proxy statement | Feb 10, 2021 | Mar 10, 2021 |
| DEF 14A | Proxy statement | May 1, 2019 | Apr 29, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2019 | Apr 16, 2019 |
| DEF 14C | Information statement | Jun 5, 2017 | Jun 5, 2017 |
| PRE 14C | Preliminary information statement | May 23, 2017 | May 23, 2017 |
| DEF 14A | Proxy statement | Apr 29, 2015 | Apr 20, 2015 |
| DEF 14C | Information statement | Dec 28, 2012 | Dec 28, 2012 |
| PRE 14C | Schedule 14c | Dec 13, 2012 | Dec 13, 2012 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SILO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514183
- Former names
- Uppercut Brands, Inc. (until Aug 14, 2020); Point Capital, Inc. (until May 14, 2019); Gold Swap Inc (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.